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In acute medicine, transient hyperoxia is not generally perceived to be detrimental, with 
many of us clinicians even feeling on the safe side when administering supplemental 
oxygen.1 However, evidence is mounting that hyperoxia, especially in the presence of 
significant coronary artery disease (CAD), may not be benign at all.2  
In recent years, studies have been emerging  which suggest negative effects of 
administration of supraphysiologic oxygen concentrations, especially in patients with acute 
myocardial ischemia.3 As a consequence, the European Society of Cardiology (ESC) has 
readjusted her guidelines for oxygen therapy in patients with acute coronary syndromes or 
myocardial infarction. In 2015, ESC recommended administration of supplemental oxygen in 
NSTEMI only to patients with a peripheral oxygen saturation (SpO2) of less than 90% or if in 
respiratory distress.4 With accruing evidence about the detrimental potential of hyperoxia, 
ESC has reconfirmed her stance in 2017 for STEMI and now advises, as a “Do-not-do” 
recommendation (Class III Evidence Level B),  against routine administration of 
supplemental oxygen to patients with acute myocardial infarction if SpO2 is 90% or higher.5   
Adverse effects of hyperoxia have also been found in patients at much lesser cardiac risk. 
The Danish PROXI trial compared laparotomies undergoing either a conservative oxygen 
regime (inspiratory oxygen fraction, FiO2 of 0.8) or a restrictive one (FiO2 of 0.3), and found 
increased long-term mortality following peri-operative hyperoxia.6 One of their post-hoc 
analyses reported an incidence of new acute coronary syndrome of 2.5% in the conservative 
oxygen group vs. 1.3% in the restrictive group.7 The long-term risk of myocardial infarction 
was also increased in the conservative group (HR 2.86; 1.10–7.44; p=0.03). This suggested 
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again, as in the AVOID trial,3 that perioperative or peri-interventional hyperoxia may 
adversely affect cardiovascular health even over prolonged periods of time. 
Hyperoxia is known to be a potent coronary vasoconstrictor.8 Hyperoxia-induced blood flow 
reduction in the left anterior descending coronary artery was reproducibly observed in 
animal research when employing novel cardiac MRI techniques such as Oxygenation-
Sensitive Cardiovascular Magnetic Resonance (OS-CMR) Imaging.9 In this study, regional 
myocardial de-oxygenation was observed during hyperoxia only downstream of significant 
coronary artery stenosis. Also, this was accompanied by impaired contractility of the 
myocardial segments subtended by the stenosed vessel, whereas contractility of healthy 
myocardium remained unaffected.  
In human studies, hyperoxia (arterial oxygen tension of more than 250 mmHg) has been 
found to reduce cardiac output by 10–15% in both healthy volunteers and patients with CAD 
or heart failure.10  Such studies into animal models and human CAD indicate that a decrease 
in ejection fraction or stroke volume under hyperoxic conditions can be attributed to 
depressed myocardial contractility in post-stenotic segments. In patients with chronic stable 
multi-vessel CAD, who were inhaling supplemental oxygen while undergoing OS-CMR 
imaging, myocardial de-oxygenation occurred in segments subtended to a significant 
stenosis and was followed by reduction in diastolic strain rate and prolongation of time-to-
peak strain.11 Both phenomena are very early responses in the ischemic sequence. 
However, they did not occur uniformly in all individuals of this study. Only approximately 
50% of these CAD patients showed worsening of tissue oxygenation, ejection fraction and 
cardiac output, whereas the other half showed respective improvement.  
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Thus, in patients with stable CAD or lesser cardiovascular risk who undergo non-cardiac 
surgery it remains unclear who may benefit from a supraphysiologic oxygen tension and 
who may not. Weighing in as a potential benefit, hyperoxia has been reported to reduce the 
incidence of postoperative surgical site infection (SSI) in several but not all randomized 
controlled trials on this topic.12 Although such effects were seen almost exclusively in 
colorectal and other abdominal surgery, the World Health Organization (WHO) has 
recommended very recently that each and every adult undergoing surgery with general 
anaesthesia should receive an FiO2 of 0.8 during the intraoperative and early post-operative 
period, in order to prevent surgical site infections.13 Practitioners of cardiovascular 
anaesthesia now face the dilemma, which of the various guidelines to follow in their 
patients, which are often at risk of both myocardial ischemia and SSI. In a survey of clinical 
routine in the UK, an FiO2 of 0.5 appeared to be standard intraoperative practice, which 
clearly differs from the recommendation of the WHO, but also from other 
recommendations to use FiO2 of 0.3.
14 
Despite a growing number of high-quality studies into pros and cons of applying high FiO2 in 
patients with known CAD or at risk thereof, current evidence remains insufficient for 
definite conclusions. Patients adapt quite variably throughout the course of CAD, and thus 
show heterogeneous responses to vasoactive stimuli such as hyperoxia11 and hypercapnia15. 
Even in patients with treated CAD, distal microvascular dysfunction may still be present and 
may contribute to adverse events during general anaesthesia. Randomized perioperative 
and long-term outcome studies in well-defined cohorts are therefore needed.  
In order to improve perioperative management, there is also a need to better characterize 
modifiers of myocardial tissue oxygenation and the impact of perioperative interventions. 
Echocardiography is sensitive for functional sequelae of myocardial ischemia or infarction. 
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Even wall motion and strain abnormalities, however, occur relatively late in the ischemic 
sequence of events, followed by ECG changes and rise in serologic biomarkers. Preceding 
changes of the myocardial tissue oxygen balance can be detected non-invasively with OS-
CMR, and this is feasible in most patients who do not have contraindications for MRI 
scans.15,16 So far, CMR studies remain a time- and resource-intensive modality, which are 
not performed routinely. As a perspective for the future, however, OS-CMR may become a 
valuable tool to assess potential triggers of perioperative myocardial injury in patients at 
risk, with hyperoxia prominently among them.  
In the future, anaesthesia practice will very likely apply individualized oxygen regimes 
depending on patients’ co-morbidities. This is already clinical routine today for selected 
diseases and patient groups (e.g., colorectal surgery, pulmonary arterial hypertension, or for 
prevention of retinopathy of prematurity, hypoplastic left heart syndrome, bleomycin-
induced lung fibrosis etc.). More evidence is required to apply similar concepts to other 
cardiovascular diseases, which are more prevalent in daily anaesthesia practice. Future 
research using novel technologies will identify patient characteristics to help us individually 
tailor oxygen tension targets and thus reduce adverse outcomes.  
Until such evidence helps us to predict, which patient benefits from supraphysiologic 
oxygen concentration and who does not, cardiovascular patients should be titrated to 
normoxemia. At any rate, we must look closer who´s under the sheep's clothing. 
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